查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1645720

全球蛋白腖市場按來源、最終用戶和應用分類 - 機會分析和產業預測，2024-2035 年

Peptone Market By Source of Peptone, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2023 年蛋白腖市場價值將達到 1.495 億美元，到 2035 年將達到 2.409 億美元，2024 年至 2035 年的複合年成長率為 4.2%。

蛋白腖是利用酵素或酸對動物、植物或微生物蛋白質源進行部分水解而獲得的水溶性蛋白質衍生物。它廣泛用於實驗室和工業培養細菌、真菌和其他微生物。它們在藥物研究、診斷和發酵過程中發揮關鍵作用，有助於抗生素、酵素和其他生技藥品的生產。

蛋白腖市場-IMG1

由於製藥、學術和醫療保健領域基於微生物學的研究不斷增加，以及疫苗、抗生素和益生菌開發力度不斷加大等因素，全球蛋白腖市場正經歷顯著成長。此外，生物技術和製藥行業的擴張也為市場成長做出了巨大貢獻。此外，感染疾病率的驚人上升導致全球對診斷實驗室的投資增加，這是蛋白腖消費的驅動力。

根據美國全國醫院感染疾病流行情況調查（2021年），光是在美國，因感染疾病和寄生蟲病而到急診室就診的人數就達380萬。其中住院患者人數預計達48.2萬人。這凸顯了對蛋白腖的迫切需求。此外，疫苗製造中蛋白腖的使用不斷增加是全球市場的主要動力。這是因為蛋白腖是疫苗生產中使用的細菌和病毒等微生物培養培養基中的主要營養來源。這些營養豐富的蛋白質水解物提供疫苗生產過程中微生物和細胞最佳生長所需的必需胺基酸、胜肽、維生素和礦物質。全球最大的開放取用研究出版商泰勒弗朗西斯 (Taylor & Francis) 於 2021 年發表的一項研究顯示，常規疫苗接種每年可挽救約 200 萬至 300 萬人的生命。由於蛋白腖在發酵過程中用於生產食品和飲料、乳製品和膳食補充劑，因此食品和飲料行業對蛋白腖的使用不斷增加將推動未來市場的成長。

然而，製造蛋白腖所需的高成本（涉及酶水解和酸水解等複雜過程）抑制了市場的成長。此外，合成或化學定義的培養基的進步為蛋白腖提供了替代品，特別是在需要精確度和可重複性的應用中，例如用於單株抗體生產的細胞培養，從而阻礙了市場的成長。相反，全球對永續生物基產品的關注正在推動蛋白腖作為發酵營養素的應用，這有望為市場成長提供有利可圖的機會。此外，人們對動物源性蛋白腖的擔憂以及製藥和食品應用向純素和無動物替代品的轉變為植物來源或微生物源性蛋白腖鋪平了道路。

全球蛋白腖市場根據蛋白腖來源、應用、最終用戶和地區進行細分。根據蛋白腖的來源，市場分為動物蛋白腖、植物蛋白腖、微生物蛋白腖和混合蛋白腖。根據最終用戶，市場可分為製藥和生物產業、研究機構、食品和飲料產業等。根據應用，市場分為細胞培養、發酵、食品和飲料等。按地區分析，涵蓋北美、歐洲、亞太地區、拉丁美洲、中東和非洲。

主要發現

  • 根據蛋白腖的來源，動物蛋白腖部分在 2023 年佔據了市場佔有率的主導地位。
  • 根據最終用戶，製藥和生物技術產業部門是 2023 年的主要股東，預計 2024 年至 2035 年期間的複合年成長率最高。
  • 根據應用，細胞培養領域預計將在 2023 年佔據最大佔有率，並在預測期內呈現最高的複合年成長率。
  • 按地區分類，北美是 2023 年蛋白腖市場的最大股東。

競爭分析

相關人員的主要利益

  • 該報告對 2019 年至 2035 年蛋白腖市場的細分市場、當前趨勢、估計和趨勢分析進行了定量分析，並確定了蛋白腖市場的主要機會。
  • 它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。
  • 波特五力分析強調了買家和供應商的潛力，使相關人員能夠做出利潤驅動的商業決策並加強供應商-買家網路。
  • 對蛋白腖市場細分進行詳細分析有助於發現市場機會。
  • 每個地區的主要國家都根據收益貢獻進行分類。
  • 市場公司的定位有利於進行對標，並能清楚了解市場公司的當前地位。
  • 報告包括區域和全球蛋白腖市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

此報告可進行客製化（需支付額外費用和時間表）

  • 國家、地區和全球層面的患者/流行病學資料
  • 監管指南
  • 根據客戶興趣提供額外的公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 擴展公司簡介列表
  • 歷史市場資料
  • SWOT 分析

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

第 4 章 蛋白腖市場依來源分類

  • 概述
  • 動物蛋白腖
  • 植物蛋白腖
  • 微生物蛋白腖
  • 混合蛋白腖

第 5 章 蛋白腖市場以最終用戶分類

  • 概述
  • 製藥和生物技術產業
  • 研究所
  • 食品和飲料
  • 其他

第6章 蛋白腖市場依應用

  • 概述
  • 細胞培養
  • 發酵
  • 食品和飲料
  • 其他

第7章 蛋白腖市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲、中東和非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品圖譜
  • 競爭儀錶板
  • 競爭熱圖
  • 主要企業定位（2019年）

第9章 公司簡介

  • Thermo Fisher Scienctific
  • Solabia Group
  • Kerry Group plc
  • Becton, Dickinson and Company
  • HiMedia Laboratories
  • Liofilchem Srl
  • Neogen Corporation
  • Merck KGaA
  • Titan Biotech Ltd.
  • Nu-Tek BioSciences
簡介目錄
Product Code: A03336

The peptone market was valued at $149.5 million in 2023 and is estimated to reach $240.9 million by 2035, exhibiting a CAGR of 4.2% from 2024 to 2035.

Peptone is a water-soluble protein derivative obtained through the partial hydrolysis of animal, plant, or microbial protein sources using enzymes or acids. They are widely used in laboratories and industries for cultivating bacteria, fungi, and other microorganisms. They play a crucial role in pharmaceutical research, diagnostics, and fermentation processes, contributing to the production of antibiotics, enzymes, and other biologics.

Peptone Market - IMG1

The global peptone market is witnessing notable growth due to factors such as increase in microbiology-based research in pharmaceutical, academic, and healthcare sectors and rise in efforts to develop vaccines, antibiotics, and probiotics. Furthermore, expansion of biotechnology and pharmaceutical industries significantly contributes toward the market growth. Moreover, alarming rise in prevalence of infectious diseases has resulted in increased investment in diagnostic labs globally, which, in turn, drives the consumption of peptones.

According to the prevalence of infectious diseases National Hospital Ambulatory Medical Care Survey: 2021, the number of emergency department visits due to infectious and parasitic diseases was recorded to be 3.8 million in the U.S. alone. Among these, hospital admissions were estimated to reach 482,000. This emphasizes the urgent need for peptone. In addition, increase in use of peptones in vaccine productions acts as a key driving force of the global market. This is attributed to the fact that peptones serves as the primary nutrient source in the growth media for culturing microorganisms, such as bacteria or viruses, that are used to produce vaccines. These nutrient-rich protein hydrolysates provide essential amino acids, peptides, vitamins, and minerals necessary for optimal microbial or cell growth during vaccine manufacturing. A 2021 study published by Taylor & Francis-one of the world's largest publishers of open access research revealed that approximately 2-3 million lives are saved every year due to routine vaccination. Rise in application of peptones in the food & beverages industry future fuels the market growth, as they are used in the fermentation processes for the production of beverages, dairy products, and dietary supplements.

However, high cost associated with manufacturing of peptones, which involves complex processes such as enzymatic or acid hydrolysis, restrains the market growth. In addition, advances in synthetic and chemically defined media are offering alternatives to peptones, particularly in applications requiring precision and reproducibility, such as cell culture for monoclonal antibody production, thereby hampering the market growth. On the contrary, the global focus on sustainable bio-based products supports the adoption of peptones as fermentation nutrients, which is expected to offer lucrative opportunities for the market growth. Moreover, concerns over animal-derived peptones and a shift toward vegan and animal-free alternatives in pharmaceuticals and food applications have opened new avenues for plant-based or microbial peptones.

The global peptone market is segmented into source of peptone, application, end user, and region. By source of peptone, the market is divided into animal peptone, plant peptone, microbial peptone, and mixed peptone. On the basis of end user, it is segregated into pharmaceutical & biotech industry, research institutions, food & beverage industry, and others. Depending on application, it is categorized into cell culture, fermentation, food & beverages, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • On the basis of source of peptone, the animal peptone segment dominated the market share in 2023.
  • Depending on end user, the pharmaceutical & biotech industry segment was the major shareholder in 2023, and is expected to grow at the highest CAGR from 2024 to 2035.
  • By application, the cell culture segment garnered the largest share in 2023, and is anticipated to exhibit the highest CAGR during the forecast period
  • Region wise, North America was the largest shareholder in the peptone market in 2023.

Competitive Analysis

The key players that operate in the global peptone market are Thermo Fisher Scientific Inc., Solabia Group, Kerry Inc, Nu-Tek Biosciences, Becton Dickinson and Company, Himedia Laboratories, Liofilchem S.R.L, Neogen Corporation, Merck KGaA, and Titan Biotech Ltd. These players have adopted acquisition, agreement, collaboration, joint venture, partnership, and product launch as their key developmental strategies to sustain the intense competition and gain a strong foothold in the global market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the peptone market analysis from 2019 to 2035 to identify the prevailing peptone market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the peptone market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global peptone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Source of Peptone

  • Animal Peptone
  • Plant Peptone
  • Microbial Peptone
  • Mixed Peptone

By End User

  • Pharmaceutical and Biotech Industry
  • Research Institutions
  • Food and Beverage Industry
  • Others

By Application

  • Cell Culture
  • Fermentation
  • Food and Beverages
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Kerry Group plc
    • Becton, Dickinson and Company
    • HiMedia Laboratories
    • Neogen Corporation
    • Merck KGaA
    • Solabia Group
    • Titan Biotech Ltd.
    • Thermo Fisher Scienctific
    • Liofilchem S.r.l
    • Nu-Tek BioSciences

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PEPTONE MARKET, BY SOURCE OF PEPTONE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Animal Peptone
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Plant Peptone
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Microbial Peptone
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Mixed Peptone
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: PEPTONE MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Pharmaceutical and Biotech Industry
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Research Institutions
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Food and Beverage Industry
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: PEPTONE MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Cell Culture
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Fermentation
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Food and Beverages
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: PEPTONE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Source of Peptone
    • 7.2.3. Market size and forecast, by End User
    • 7.2.4. Market size and forecast, by Application
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Source of Peptone
      • 7.2.5.1.2. Market size and forecast, by End User
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Source of Peptone
      • 7.2.5.2.2. Market size and forecast, by End User
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Source of Peptone
      • 7.2.5.3.2. Market size and forecast, by End User
      • 7.2.5.3.3. Market size and forecast, by Application
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Source of Peptone
    • 7.3.3. Market size and forecast, by End User
    • 7.3.4. Market size and forecast, by Application
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Source of Peptone
      • 7.3.5.1.2. Market size and forecast, by End User
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Source of Peptone
      • 7.3.5.2.2. Market size and forecast, by End User
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Source of Peptone
      • 7.3.5.3.2. Market size and forecast, by End User
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Source of Peptone
      • 7.3.5.4.2. Market size and forecast, by End User
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Source of Peptone
      • 7.3.5.5.2. Market size and forecast, by End User
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Source of Peptone
      • 7.3.5.6.2. Market size and forecast, by End User
      • 7.3.5.6.3. Market size and forecast, by Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Source of Peptone
    • 7.4.3. Market size and forecast, by End User
    • 7.4.4. Market size and forecast, by Application
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Source of Peptone
      • 7.4.5.1.2. Market size and forecast, by End User
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Source of Peptone
      • 7.4.5.2.2. Market size and forecast, by End User
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Source of Peptone
      • 7.4.5.3.2. Market size and forecast, by End User
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Source of Peptone
      • 7.4.5.4.2. Market size and forecast, by End User
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Source of Peptone
      • 7.4.5.5.2. Market size and forecast, by End User
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Source of Peptone
      • 7.4.5.6.2. Market size and forecast, by End User
      • 7.4.5.6.3. Market size and forecast, by Application
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Source of Peptone
    • 7.5.3. Market size and forecast, by End User
    • 7.5.4. Market size and forecast, by Application
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Source of Peptone
      • 7.5.5.1.2. Market size and forecast, by End User
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Source of Peptone
      • 7.5.5.2.2. Market size and forecast, by End User
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Source of Peptone
      • 7.5.5.3.2. Market size and forecast, by End User
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Source of Peptone
      • 7.5.5.4.2. Market size and forecast, by End User
      • 7.5.5.4.3. Market size and forecast, by Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2019

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scienctific
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Solabia Group
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Kerry Group plc
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. HiMedia Laboratories
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Liofilchem S.r.l
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Neogen Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Merck KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Titan Biotech Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Nu-Tek BioSciences
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments